Delayed diagnosis of haemophilia in India is leading to preventable vision loss for patients suffering from intra-ocular bleeding [1].
This diagnostic gap is critical because the window for effective treatment is very short. When bleeding occurs within the eye, the lack of a timely diagnosis often results in permanent blindness that could have been avoided with proper medical intervention [1].
The issue is compounded by the nature of the symptoms. Ocular bleeding in haemophilia patients is often ambiguous, making it difficult for general practitioners or patients to recognize the condition early [1]. By the time the bleeding is identified as a symptom of haemophilia, the window for saving the patient's sight has frequently closed [1].
This trend in India mirrors a broader global crisis in hematology. Approximately 75% of individuals with haemophilia remain undiagnosed worldwide [2]. This lack of identification means millions of people are living with a chronic bleeding disorder without the necessary prophylactic care, or emergency protocols, to prevent organ and tissue damage.
In India, the medical community responsible for diagnosis faces the challenge of identifying the disorder before life-altering complications occur. The current state of diagnosis allows for a pattern where the first clear indicator of the disease is a severe event—such as vision loss—rather than a preventative screening [1].
Medical professionals said that the ambiguity of early symptoms requires a higher index of suspicion for bleeding disorders when patients present with unexplained ocular issues. Without a systemic shift in how these symptoms are screened, the risk of avoidable blindness remains high for the undiagnosed population [1].
“Delayed diagnosis of haemophilia in India is leading to preventable vision loss.”
The link between haemophilia and vision loss highlights a systemic failure in early screening and primary care awareness. Because intra-ocular bleeding requires immediate intervention to prevent permanent damage, the 'diagnostic gap' is not merely a statistical failure but a direct cause of disability. This suggests that integrating hematological screening into standard ophthalmic care could reduce the incidence of preventable blindness in regions with high undiagnosed rates.
